Skip to content

EV / sales at other companies

Teledyne Technologies logo
Teledyne TechnologiesTDY
4.8×+0.3×
Leidos Holdings logo
Leidos HoldingsLDOS
1.4×0.0×
RadNet logo
RadNetRDNT
2.7×+0.2×
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
2.1×-0.3×
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
1.7×+0.3×
iRadimed logo
iRadimedIRMD
8.2×+0.6×

Other financials

Income statement

See full
Revenue$216.0M+1.5%
Gross profit$72.6M-5.3%
Operating income$14.4M-34.8%
Net income-$8.1M-217%
EPS (diluted)-$0.19-212%

Balance sheet

See full
Cash & equivalents$87.7M-73.6%
Total debt$380.6M-36.2%
Total equity$474.2M-13.7%
Total assets$1.1B-19.8%

Cash flow

See full
Operating cash flow-$1.5M-109%
CapEx$6.2M-8.8%
Free cash flow-$7.7M-179%

Valuation

See full
Market cap$433.69M+34.8%
Enterprise value$726.59M+24.0%
P/S0.5×+0.1×

Profitability

See full
Gross margin33.6%-0.2pp
Operating margin-4.4%-9.9pp
Net margin-16.3%-20.3pp
FCF margin-3.6%-8.2pp

Returns & leverage

See full
Return on equity-25.8%-31.8pp
Debt / equity0.8×-0.3×
Current ratio3.2×-0.8×

Where this comes from

Calculated from Varex Imaging Corporation’s reported figures.

Based on the most recent quarter.

The official record: Varex Imaging Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Varex Imaging Corporation's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Varex Imaging Corporation's EV / sales?
Varex Imaging Corporation (VREX) reported EV / sales of 0.9× in Q1 2026.
How has Varex Imaging Corporation's EV / sales changed year-over-year?
Varex Imaging Corporation's EV / sales increased by 24.2% year-over-year, from 0.7× to 0.9×.
What is the long-term trend for Varex Imaging Corporation's EV / sales?
Over 5 years (2020 to 2025), Varex Imaging Corporation's EV / sales has grown at a -6.7% compound annual growth rate (CAGR), from 1.2× to 0.9×.
What does EV / sales mean?
Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.